181 related articles for article (PubMed ID: 21874310)
21. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
[TBL] [Abstract][Full Text] [Related]
22. Multi-institutional experience of ductal carcinoma in situ in black vs white patients treated with breast-conserving surgery and whole breast radiation therapy.
Nelson C; Bai H; Neboori H; Takita C; Motwani S; Wright JL; Hobeika G; Haffty BG; Jones T; Goyal S; Moran MS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e279-83. PubMed ID: 22672752
[TBL] [Abstract][Full Text] [Related]
23. Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast.
Bailes AA; Kuerer HM; Lari SA; Jones LA; Brewster AM
Cancer; 2013 Jan; 119(1):150-7. PubMed ID: 22736444
[TBL] [Abstract][Full Text] [Related]
24. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES
J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776
[TBL] [Abstract][Full Text] [Related]
25. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
26. Race and the prognostic influence of p53 in women with breast cancer.
Dookeran KA; Dignam JJ; Holloway N; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S
Ann Surg Oncol; 2012 Jul; 19(7):2334-44. PubMed ID: 22434242
[TBL] [Abstract][Full Text] [Related]
27. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
28. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
[TBL] [Abstract][Full Text] [Related]
29. Ductal carcinoma in situ (DCIS): posttreatment follow-up care among Latina and non-Latina White women.
López ME; Kaplan CP; Nápoles AM; Livaudais JC; Hwang ES; Stewart SL; Bloom J; Karliner L
J Cancer Surviv; 2013 Jun; 7(2):219-26. PubMed ID: 23408106
[TBL] [Abstract][Full Text] [Related]
30. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Kerlikowske K; Molinaro AM; Gauthier ML; Berman HK; Waldman F; Bennington J; Sanchez H; Jimenez C; Stewart K; Chew K; Ljung BM; Tlsty TD
J Natl Cancer Inst; 2010 May; 102(9):627-37. PubMed ID: 20427430
[TBL] [Abstract][Full Text] [Related]
31. Excising Additional Margins at Initial Breast-Conserving Surgery (BCS) Reduces the Need for Re-excision in a Predominantly African American Population: A Report of a Randomized Prospective Study in a Public Hospital.
Jones V; Linebarger J; Perez S; Gabram S; Okoli J; Bumpers H; Burns B; Mosunjac M; Rizzo M
Ann Surg Oncol; 2016 Feb; 23(2):456-64. PubMed ID: 26254169
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer.
Moran MS; Yang Q; Harris LN; Jones B; Tuck DP; Haffty BG
Cancer; 2008 Nov; 113(9):2565-74. PubMed ID: 18816610
[TBL] [Abstract][Full Text] [Related]
33. Ductal carcinoma in situ of the breast - Long term results from a twenty-year cohort.
Co M; Kwong A
Cancer Treat Res Commun; 2018; 14():17-20. PubMed ID: 30104003
[TBL] [Abstract][Full Text] [Related]
34. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Rudloff U; Brogi E; Brockway JP; Goldberg JI; Cranor M; Wynveen CA; Nehhozina T; Reiner AS; Patil S; Van Zee KJ
Cancer; 2009 Mar; 115(6):1203-14. PubMed ID: 19170233
[TBL] [Abstract][Full Text] [Related]
35. Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ.
Kaplan CP; Nápoles AM; Hwang ES; Bloom J; Stewart S; Nickleach D; Karliner L
J Womens Health (Larchmt); 2011 Feb; 20(2):215-23. PubMed ID: 21128819
[TBL] [Abstract][Full Text] [Related]
36. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
37. Race and ethnicity and breast cancer outcomes in an underinsured population.
Komenaka IK; Martinez ME; Pennington RE; Hsu CH; Clare SE; Thompson PA; Murphy C; Zork NM; Goulet RJ
J Natl Cancer Inst; 2010 Aug; 102(15):1178-87. PubMed ID: 20574040
[TBL] [Abstract][Full Text] [Related]
38. Elevated Risk of Radiation Therapy-Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA Breast Cancer.
Xie L; Bao X; Cai T; Silva SG; Ma J; Zhang Z; Guo X; Marks LB
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):275-284. PubMed ID: 31201893
[TBL] [Abstract][Full Text] [Related]
39. A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk.
Klimov S; Miligy IM; Gertych A; Jiang Y; Toss MS; Rida P; Ellis IO; Green A; Krishnamurti U; Rakha EA; Aneja R
Breast Cancer Res; 2019 Jul; 21(1):83. PubMed ID: 31358020
[TBL] [Abstract][Full Text] [Related]
40. Affluence Does Not Influence Breast Cancer Outcomes in African American Women.
Ricks-Santi LJ; Barley B; Winchester D; Sultan D; McDonald J; Kanaan Y; Pearson-Fields A; Sutton AL; Sheppard V; Williams C
J Health Care Poor Underserved; 2018; 29(1):509-529. PubMed ID: 29503315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
